Preliminary experiments point out conolidine may well inhibit certain ion channels, decreasing neuronal excitability and restricting agony indicators. This system is especially relevant in neuropathic suffering, where irregular signaling results in persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to soreness perceptio... https://hannesz258tro0.wikilima.com/user